LeMaitre Vascular Company Insiders

LMAT Stock  USD 87.66  1.06  1.22%   
LeMaitre Vascular's insiders are aggressively selling. The analysis of insiders' sentiment of trading LeMaitre Vascular stock suggests that vertually all insiders are panicking at this time. LeMaitre Vascular employs about 651 people. The company is managed by 16 executives with a total tenure of roughly 139 years, averaging almost 8.0 years of service per executive, having 40.69 employees per reported executive.
George LeMaitre  Chairman
Chairman and CEO
David Roberts  President
President Director

Insider Sentiment 0

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-08-11John A RoushDisposed 6561 @ 92.55View
2025-08-08John A RoushDisposed 939 @ 93.49View
2025-08-06George W LemaitreDisposed 100000 @ 93.51View
2025-05-20George W LemaitreDisposed 4399 @ 85.1View
2025-05-19George W LemaitreDisposed 76868 @ 85.79View
2025-05-16George W LemaitreDisposed 18733 @ 84.77View
2025-03-12Trent G KamkeDisposed 2009 @ 82.12View
Monitoring LeMaitre Vascular's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LeMaitre Vascular. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy LeMaitre Stock please use our How to Invest in LeMaitre Vascular guide.

LeMaitre Vascular's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with LeMaitre Vascular's future performance. Based on our forecasts, it is anticipated that LeMaitre will maintain a workforce of slightly above 650 employees by March 2026.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

LeMaitre Vascular Management Team Effectiveness

The company has return on total asset (ROA) of 0.0794 % which means that it generated a profit of $0.0794 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1502 %, meaning that it created $0.1502 on every $100 dollars invested by stockholders. LeMaitre Vascular's management efficiency ratios could be used to measure how well LeMaitre Vascular manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.06 in 2026. Return On Capital Employed is likely to drop to 0.06 in 2026. At this time, LeMaitre Vascular's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 666.3 M in 2026, whereas Non Current Liabilities Other is likely to drop slightly above 283 K in 2026.
Net Income Applicable To Common Shares is likely to gain to about 24.9 M in 2026, whereas Common Stock Shares Outstanding is likely to drop slightly above 17.6 M in 2026. LeMaitre Vascular maintains a total of 22.69 Million outstanding shares. The majority of LeMaitre Vascular outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in LeMaitre Vascular to benefit from reduced commissions. Accordingly, institutional holders are subject to a different set of regulations than regular investors in LeMaitre Vascular. Please pay attention to any change in the institutional holdings of LeMaitre Vascular as this could imply that something significant has changed or is about to change at the company. Also note that almost one million sixty-six thousand two hundred fourty-two invesors are currently shorting LeMaitre Vascular expressing very little confidence in its future performance.
 
Shares in Circulation  
First Issued
2004-03-31
Previous Quarter
22.9 M
Current Value
24.4 M
Avarage Shares Outstanding
17.3 M
Quarterly Volatility
4.5 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
At this time, LeMaitre Vascular's Dividend Yield is comparatively stable compared to the past year. Dividend Payout Ratio is likely to gain to 0.46 in 2026, despite the fact that Dividends Paid is likely to grow to (12.3 M). Net Income Applicable To Common Shares is likely to gain to about 24.9 M in 2026, whereas Common Stock Shares Outstanding is likely to drop slightly above 17.6 M in 2026.

LeMaitre Vascular Workforce Comparison

LeMaitre Vascular is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 84,738. LeMaitre Vascular maintains roughly 651 in number of employees contributing less than 1% to equities under Health Care industry.

LeMaitre Vascular Profit Margins

The company has Profit Margin (PM) of 0.22 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.760.79
Sufficiently Down
Slightly volatile

LeMaitre Vascular Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific LeMaitre Vascular insiders, such as employees or executives, is commonly permitted as long as it does not rely on LeMaitre Vascular's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, LeMaitre Vascular insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2026-03-01
1.0
4
4
 5,023 
 5,023 
2025-12-01
1.6795
131
78
 146,576 
 58,308 
2025-09-01
3.1
62
20
 42,225 
 206,306 
2025-06-01
5.0833
61
12
 38,501 
 142,119 
2025-03-01
3.6818
81
22
 13,990 
 18,179 
2024-12-01
1.4026
108
77
 90,515 
 44,464 
2024-09-01
5.75
46
8
 3,333 
 103,868 
2024-06-01
3.3846
44
13
 5,599 
 225,425 
2024-03-01
1.7073
70
41
 68,370 
 209,590 
2023-12-01
1.3934
85
61
 120,187 
 115,556 
2023-09-01
29.0
29
1
 93.14 
 625.00 
2023-06-01
1.3571
38
28
 66,703 
 305,140 
2023-03-01
3.1818
35
11
 28,091 
 54,106 
2022-12-01
1.4255
67
47
 145,360 
 69,576 
2022-09-01
1.7692
23
13
 32,221 
 65,919 
2022-03-01
4.2
21
5
 12,710 
 22,187 
2021-12-01
1.2
54
45
 155,043 
 84,946 
2021-09-01
1.75
21
12
 408.00 
 3,672 
2021-06-01
1.037
28
27
 49,218 
 312,047 
2021-03-01
1.5
24
16
 24,777 
 243,082 
2020-12-01
0.7684
73
95
 314,488 
 539,338 
2020-09-01
1.6
24
15
 45,972 
 64,025 
2020-06-01
19.0
19
1
 40,275 
 20,000 
2020-03-01
2.3
23
10
 18,233 
 80,875 
2019-12-01
0.6724
39
58
 237,298 
 561,365 
2019-09-01
0.8387
26
31
 134,643 
 320,173 
2019-06-01
13.0
26
2
 77,249 
 77,032 
2019-03-01
0.75
3
4
 47,494 
 64,098 
2018-12-01
2.2727
25
11
 181,780 
 52,203 
2018-09-01
0.9091
20
22
 124,188 
 201,067 
2018-06-01
1.3529
23
17
 54,758 
 133,748 
2018-03-01
0.1111
1
9
 16,328 
 151,918 
2017-12-01
8.0
16
2
 141,561 
 11,893 
2017-09-01
0.5455
30
55
 220,721 
 604,749 
2017-06-01
0.913
21
23
 185,960 
 460,046 
2017-03-01
0.5
3
6
 74,666 
 89,531 
2016-12-01
2.0
8
4
 3,100 
 35,995 
2016-09-01
0.6735
33
49
 405,968 
 437,864 
2016-06-01
0.2105
8
38
 79,875 
 310,179 
2016-03-01
1.0
11
11
 16,810 
 53,628 
2015-12-01
0.3922
20
51
 226,737 
 630,259 
2015-09-01
0.5352
38
71
 623,369 
 797,732 
2015-06-01
0.4872
19
39
 101,235 
 286,805 
2015-03-01
0.2424
8
33
 135,807 
 259,579 
2014-09-01
1.2308
16
13
 402,899 
 89,693 
2014-06-01
0.3333
2
6
 52,061 
 40,032 
2014-03-01
0.1667
5
30
 31,000 
 94,495 
2013-12-01
0.0769
2
26
 168,613 
 258,150 
2013-09-01
0.5429
19
35
 335,573 
 177,860 
2013-06-01
0.2353
4
17
 3,497 
 53,433 
2013-03-01
0.3889
7
18
 42,263 
 77,367 
2012-12-01
0.1176
2
17
 104,192 
 121,606 
2012-09-01
0.3514
13
37
 283,230 
 75,190 
2012-06-01
0.5
4
8
 14,000 
 10,718 
2011-12-01
1.3333
4
3
 5,500 
 1,619 
2011-09-01
0.6818
15
22
 225,389 
 23,720 
2011-06-01
0.1765
3
17
 41,500 
 168,916 
2011-03-01
0.1786
5
28
 41,891 
 106,978 
2010-12-01
0.7368
14
19
 31,637 
 74,717 
2010-09-01
0.2308
18
78
 225,305 
 185,762 
2010-06-01
0.2821
11
39
 19,000 
 132,595 
2010-03-01
0.1739
4
23
 7,552 
 20,121 
2009-12-01
0.48
24
50
 51,604 
 62,796 
2009-09-01
1.1538
15
13
 206,874 
 6,513 
2009-06-01
0.5
2
4
 1,600 
 2,860 
2008-12-01
0.4
2
5
 2,000 
 3,854 
2008-09-01
1.25
10
8
 126,276 
 12,631 
2008-06-01
0.5
8
16
 150,389 
 52,938 
2008-03-01
0.0909
1
11
 200.00 
 59,457 
2007-06-01
5.0
5
1
 18,000 
 3,500 
2007-03-01
2.0
2
1
 45,330 
 44,580 
2006-12-01
3.1111
28
9
 2,703,525 
 226,193 

LeMaitre Vascular Notable Stakeholders

A LeMaitre Vascular stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as LeMaitre Vascular often face trade-offs trying to please all of them. LeMaitre Vascular's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting LeMaitre Vascular's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
MD FACSFounder BoardProfile
George LeMaitreChairman and CEOProfile
David RobertsPresident DirectorProfile
Kimberly CieslakVice President - MarketingProfile
Ryan ConnellyVice President - Research & DevelopmentProfile
Laurie ChurchillSenior Vice President General CounselProfile
Stephane MaierVice President EMEA OperationsProfile
Andrew HodgkinsonSenior Vice President - Clinical, Regulatory and Quality AffairsProfile
Joseph PellegrinoCFO, Principal Accounting Officer and SecretaryProfile
Trent KamkeSr. VP of OperationsProfile
Daniel MumfordDirector ResourcesProfile
Jonathan NgauSenior TechnologyProfile
Jacob PetersenSenior InternationalProfile
Dorian CPAChief OfficerProfile
Maik HelmersSenior EuropeProfile
David HissongGeneral CounselProfile
String symbol = request.getParameter("s");

About LeMaitre Vascular Management Performance

The success or failure of an entity such as LeMaitre Vascular often depends on how effective the management is. LeMaitre Vascular management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of LeMaitre management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the LeMaitre management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.09  0.06 
Return On Capital Employed 0.09  0.06 
Return On Assets 0.07  0.04 
Return On Equity 0.13  0.12 
Please note, the imprecision that can be found in LeMaitre Vascular's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of LeMaitre Vascular. Check LeMaitre Vascular's Beneish M Score to see the likelihood of LeMaitre Vascular's management manipulating its earnings.

LeMaitre Vascular Workforce Analysis

Traditionally, organizations such as LeMaitre Vascular use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare LeMaitre Vascular within its industry.

LeMaitre Vascular Manpower Efficiency

Return on LeMaitre Vascular Manpower

Revenue Per Employee337.7K
Revenue Per Executive13.7M
Net Income Per Employee67.6K
Net Income Per Executive2.8M
Working Capital Per Employee570.8K
Working Capital Per Executive23.2M

Additional Tools for LeMaitre Stock Analysis

When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.